Upgrade to SI Premium - Free Trial

Regeneron Pharma (REGN) PT Raised to $352 at Cowen

November 5, 2019 3:42 PM
Cowen analyst Yaron Werber raised the price target on Regeneron Pharma (NASDAQ: REGN) to $352.00 (from $349.00) while ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Analyst Comments Analyst EPS View Analyst PT Change

Next Articles